Selective versus total insulin resistance: a pathogenic paradox.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicmTOR signaling in growth control and diseaseNaringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceCholesterol feedback: from Schoenheimer's bottle to Scap's MELADLFree fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolismAn Overview of Murine High Fat Diet as a Model for Type 2 Diabetes MellitusInsulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic DisordersSelective Insulin Resistance in the KidneyInsulin resistance in development and progression of nonalcoholic fatty liver diseaseResveratrol Inhibition of Cellular Respiration: New Paradigm for an Old MechanismDoes Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?Pathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxLessons from mouse models of high-fat diet-induced NAFLDInsulin resistance in clinical and experimental alcoholic liver diseaseLiver steatosis in hepatitis C patientsInsulin resistance, hyperglycemia, and atherosclerosisNotch signaling as a novel regulator of metabolismInsulin resistance and environmental pollutants: experimental evidence and future perspectivesPhosphoinositides: Key modulators of energy metabolismInsulin signaling regulates fatty acid catabolism at the level of CoA activationThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease - A multisystem disease?Homeostasis, inflammation, and disease susceptibilityAkt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathwaysRegulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2What is metabolic syndrome, and why are children getting it?Molecular and Cellular Mechanisms of Cardiovascular Disorders in DiabetesCeacam1 deletion causes vascular alterations in large vesselsActivation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK PathwayRetinoids induced Pck1 expression and attenuated insulin-mediated suppression of its expression via activation of retinoic acid receptor in primary rat hepatocytesRole of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistanceImpaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoproteinOxidative stress and diabetic complicationsThe Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.The Sweet Path to Metabolic Demise: Fructose and Lipid SynthesisEndocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders.Fructose: it's "alcohol without the buzz".GLUT4 is sorted to vesicles whose accumulation beneath and insertion into the plasma membrane are differentially regulated by insulin and selectively affected by insulin resistanceProgrammed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance.
P2860
Q24563381-468EE1BE-82A3-41C2-B04F-653C981CD947Q24634174-0CAD88FA-CA4D-454C-B5E9-A57DD25FFB5EQ24648189-1FF570CC-D319-46C1-AA03-3270450D2445Q24652984-2FE11788-1E18-4646-9A4B-3F8D6C3744C2Q24810354-9E1A6021-FCB7-4106-B9A4-7D5F8666932CQ26740006-3AED845B-7DD5-4C03-9181-83559EE5D7FFQ26740443-512CF554-E04E-4B5C-B8FF-25B29296EBA9Q26744243-BA1B8AA0-8A98-463B-87FC-025A6C38205FQ26748687-3562EC40-FFA6-4265-A64A-D11626DBFB6DQ26753034-909F9A42-0399-4407-994B-FF1675F5ABE8Q26798161-B083E4CD-3A88-4848-9188-B97947051516Q26820876-24B7F1E7-1AB1-4C83-A3C3-B07E0B767854Q26829532-F2FF65DE-4FBE-4596-B2D5-8B5BEF95CAF4Q26865988-D45257B3-9B6B-4A2E-8AE1-C2589BA8B737Q27010631-B38EC657-EB8C-49FB-AFFD-0717FD9A73B3Q27011696-700B1C26-B2C3-498E-9D72-64304AC4705FQ27014152-3E9179A5-A635-4851-856C-D8523A1FDB18Q27021737-D0156033-7E4A-4902-90B7-088E70D5CC52Q27022953-1351BE5E-8ADA-4BC7-AFFE-77FA45282A87Q27334898-D38CCCBC-2C93-451C-84E7-4434F37618EDQ28078754-9CB284DD-F821-40E2-AD01-569702A5BEACQ28079077-C2C1E0B5-9180-40BE-9AD0-A0C5D31C9580Q28082739-6233FA23-3FC0-46F3-B30D-7119B0C36790Q28242180-969BB980-CDBE-4484-B0E7-5BE63DE23F4BQ28272571-45FDFD14-BA48-431E-95F2-A191C398C868Q28385817-2C26EA4B-4603-4EF2-AD8C-53C9138DD158Q28395675-454012CC-6167-4C46-8878-FE5FE294919FQ28505518-7FDEAE50-8DF1-4056-B51A-520D33BBF17CQ28546710-E368EA40-6500-466D-976C-367113FC2CB8Q28566684-7B3C472F-B4AA-4362-8F1D-D7CC455C398CQ28568969-5F04605D-F649-4F8A-A6D8-AEDFCF97CCF1Q28583188-9B1F5415-7A11-4034-9DD4-37BD96203814Q29615423-91A9AEA2-F3EF-43D2-AD96-E39C729DFB64Q30235555-E8ED076B-1DDC-4704-9A71-C533B19B26EFQ30241943-4F4E2C57-9ADD-49A2-B436-7C01C22EA6F3Q30249128-5A77E52B-4907-41A6-8868-617D0AD227E8Q30402800-129E04DC-C5DD-4279-8F99-C1A278722F56Q30428239-8E73BB10-222C-47F8-9465-9D27A56BC79BQ30435746-F7603922-0AB6-4905-9A38-B90862CE5752Q30557551-377980FA-E60D-4F10-88A9-88BAC5B635A9
P2860
Selective versus total insulin resistance: a pathogenic paradox.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective versus total insulin resistance: a pathogenic paradox.
@en
Selective versus total insulin resistance: a pathogenic paradox.
@nl
type
label
Selective versus total insulin resistance: a pathogenic paradox.
@en
Selective versus total insulin resistance: a pathogenic paradox.
@nl
prefLabel
Selective versus total insulin resistance: a pathogenic paradox.
@en
Selective versus total insulin resistance: a pathogenic paradox.
@nl
P1433
P1476
Selective versus total insulin resistance: a pathogenic paradox.
@en
P2093
Michael S Brown
P356
10.1016/J.CMET.2007.12.009
P577
2008-02-01T00:00:00Z